Cover Image
市場調查報告書

H1N1感染症:全球臨床實驗檢討

H1N1 Infection Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 320833
出版日期 內容資訊 英文 107 Pages
訂單完成後即時交付
價格
Back to Top
H1N1感染症:全球臨床實驗檢討 H1N1 Infection Global Clinical Trials Review, H2, 2014
出版日期: 2014年11月30日 內容資訊: 英文 107 Pages
簡介

本報告提供H1N1感染症的臨床試驗相關之基本資料及數據,為您彙整實驗數量及受驗者的募集情況,各階段趨勢,臨床試驗的主要製藥企業及研究機關簡介等資料。

簡介

  • H1N1感染症
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區的主要5個國家的臨床實驗數量
    • 歐洲的主要5個國家的臨床實驗數量
    • 北美的主要國家的臨床實驗數量
    • 中東·非洲的主要國家的臨床實驗數量
    • 中南美的主要5個國家臨床實驗數量

G7各國臨床實驗數量:感染症臨床實驗上H1N1感染症所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:感染症臨床實驗上H1N1感染症所佔的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗上目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

H1N1感染症治療藥臨床實驗的主要參與企業

有潛力的藥劑

最新臨床實驗新聞 H1N1感染症

臨床實驗簡介

  • 主要企業臨床實驗概要
    • GlaxoSmithKline plc
    • Novartis AG
    • Sanofi
    • Serum Institute of India Limited
    • Cadila Pharmaceuticals Ltd.
    • Vaxart, Inc.
    • Microgen Scientific Industrial Company for Immunobiological Medicines
    • F. Hoffmann-La Roche Ltd.
    • Chiltern International Ltd.
    • Bharat Biotech International Limited
  • 有代表性的研究機關·醫院臨床實驗概要
    • The National Institute of Allergy and Infectious Diseases
    • University of British Columbia
    • University of Rochester
    • Institut National de la Sante et de la Recherche Medicale
    • University Health Network
    • National Heart, Lung, and Blood Institute
    • Hadassah Medical Organization
    • The University of Hong Kong
    • University Hospitals of Leicester NHS Trust

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2446CTIDB

GlobalData's clinical trial report, "H1N1 Infection Global Clinical Trials Review, H2, 2014" provides data on the H1N1 Infection clinical trial scenario. This report provides elemental information and data relating to the clinical trials on H1N1 Infection. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating H1N1 Infection. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • H1N1 Infection
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of H1N1 Infection to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of H1N1 Infection to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of H1N1 Infection
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in H1N1 Infection Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on H1N1 Infection
    • Oct 14, 2014: Vaxart's Tablet Vaccine for H1N1 Influenza Generates Protective Immunity Equivalent to Injectable in Phase I Clinical Study
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Serum Institute of India Limited
      • Clinical Trial Overview of Serum Institute of India Limited
      • Cadila Pharmaceuticals Ltd.
      • Clinical Trial Overview of Cadila Pharmaceuticals Ltd.
      • Vaxart, Inc.
      • Clinical Trial Overview of Vaxart, Inc.
      • Microgen Scientific Industrial Company for Immunobiological Medicines
      • Clinical Trial Overview of Microgen Scientific Industrial Company for Immunobiological Medicines
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Chiltern International Ltd.
      • Clinical Trial Overview of Chiltern International Ltd.
      • Bharat Biotech International Limited
      • Clinical Trial Overview of Bharat Biotech International Limited
    • Clinical Trial Overview of Top Institutes / Government
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • University of British Columbia
      • Clinical Trial Overview of University of British Columbia
      • University of Rochester
      • Clinical Trial Overview of University of Rochester
      • Institut National de la Sante et de la Recherche Medicale
      • Clinical Trial Overview of Institut National de la Sante et de la Recherche Medicale
      • University Health Network
      • Clinical Trial Overview of University Health Network
      • National Heart, Lung, and Blood Institute
      • Clinical Trial Overview of National Heart, Lung, and Blood Institute
      • Hadassah Medical Organization
      • Clinical Trial Overview of Hadassah Medical Organization
      • The University of Hong Kong
      • Clinical Trial Overview of The University of Hong Kong
      • University Hospitals of Leicester NHS Trust
      • Clinical Trial Overview of University Hospitals of Leicester NHS Trust
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • H1N1 Infection Therapeutics, Global, Clinical Trials by Region, 2014*
  • H1N1 Infection Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • H1N1 Infection Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • H1N1 Infection Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • H1N1 Infection Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • H1N1 Infection Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • H1N1 Infection Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • H1N1 Infection Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of H1N1 Infection to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • H1N1 Infection Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • H1N1 Infection Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of H1N1 Infection to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • H1N1 Infection Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • H1N1 Infection Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • H1N1 Infection Therapeutics, Global, Clinical Trials by Phase, 2014*
  • H1N1 Infection Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • H1N1 Infection Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • H1N1 Infection Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • H1N1 Infection Therapeutics, Global, Suspended Clinical Trials, 2014*
  • H1N1 Infection Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • H1N1 Infection Therapeutics, Global, Terminated Clinical Trials, 2014*
  • H1N1 Infection Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • H1N1 Infection Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • H1N1 Infection Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • H1N1 Infection Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • H1N1 Infection Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Serum Institute of India Limited, 2014*
  • H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Cadila Pharmaceuticals Ltd., 2014*
  • H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Vaxart, Inc., 2014*
  • H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Microgen Scientific Industrial Company for Immunobiological Medicines, 2014*
  • H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiltern International Ltd., 2014*
  • H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Bharat Biotech International Limited, 2014*
  • H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014*
  • H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by University of British Columbia, 2014*
  • H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rochester, 2014*
  • H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut National de la Sante et de la Recherche Medicale, 2014*
  • H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2014*
  • H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014*
  • H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2014*
  • H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Hong Kong, 2014*
  • H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals of Leicester NHS Trust, 2014*

List of Figures

  • H1N1 Infection Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • H1N1 Infection Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • H1N1 Infection Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • H1N1 Infection Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • H1N1 Infection Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • H1N1 Infection Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • H1N1 Infection Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • H1N1 Infection Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of H1N1 Infection to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • H1N1 Infection Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • H1N1 Infection Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of H1N1 Infection to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • H1N1 Infection Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • H1N1 Infection Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • H1N1 Infection Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • H1N1 Infection Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • H1N1 Infection Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • H1N1 Infection Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • H1N1 Infection Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • H1N1 Infection Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • H1N1 Infection Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • H1N1 Infection Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • H1N1 Infection Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top